Sarepta decision to halt Duchenne treatment continues to frustrate families; FDA reinstate a quarter of DOGE cuts; Contract research organizations report higher than expected pharma and biotech Q2 ...

John will offer his entrepreneurial and marketing insights on brand innovation to help healthcare marketers make a splash in a sea of change.

In a warning letter, the Food and Drug Administration said Glenmark Pharmaceuticals failed to properly investigate flaws with a generic drug that ProPublica found was linked to U.S. deaths.

With an eye on protecting consumers from those risks this summer, Band-Aid has launched its latest innovation: Waterproof ...